NBQX attenuates relapse of nicotine seeking but not nicotine and methamphetamine self-administration in rats

References

• Ahmed SH, Koob GF. 1998. Transition from moderate to excessive drug intake: change in hedonic set point. Science. 282(5387):298–300.
   PubMed Web of Science ®Google Scholar
• Alasmari F, Goodwani S, McCullumsmith RE, Sari Y. 2018. Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence. Prog Neurobiol. 171:32–49.
   PubMed Web of Science ®Google Scholar
• Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, Dusek L, Fadda P, Micale V, Sulcova A, et al. 2014. Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms. Front Pharmacol. 5:44.
   PubMed Web of Science ®Google Scholar
• Amidfar M, Woelfer M, Réus GZ, Quevedo J, Walter M, Kim Y-K. 2019. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: evidence from translational research. Prog Neuropsychopharmacol Biol Psychiatry. 94:109668.
   PubMed Web of Science ®Google Scholar
• Antinori S, Fattore L, Saba P, Fratta W, Gessa GL, Devoto P. 2018. Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex. Addict Biol. 23(2):556–568.
   PubMed Web of Science ®Google Scholar
• Babinska Z, Ruda-Kucerova J. 2017. Differential characteristics of ketamine self-administration in the olfactory bulbectomy model of depression in male rats. Exp Clin Psychopharmacol. 25(2):84–93.
   PubMed Web of Science ®Google Scholar
• Babinska Z, Ruda-Kucerova J, Amchova P, Merhautova J, Dusek L, Sulcova A. 2016. Olfactory bulbectomy increases reinstatement of methamphetamine seeking after a forced abstinence in rats. Behav Brain Res. 297:20–27.
   PubMed Web of Science ®Google Scholar
• Bäckström P, Hyytiä P. 2003. Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats. Psychopharmacology. 166(1):69–76.
   PubMed Web of Science ®Google Scholar
• Bäckström P, Hyytiä P. 2004. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol Clin Exp Res. 28(4):558–565.
   PubMed Web of Science ®Google Scholar
• Bäckström P, Hyytiä P. 2006. Ionotropic and metabotropic glutamate receptor antagonism attenuates cue-induced cocaine seeking. Neuropsychopharmacology. 31(4):778–786.
   PubMed Web of Science ®Google Scholar
• Barnes SA, Sheffler DJ, Semenova S, Cosford NDP, Bespalov A. 2018. Metabotropic glutamate receptor 5 as a target for the treatment of depression and smoking: robust preclinical data but inconclusive clinical efficacy. Biol Psychiatry. 83(11):955–962.
   PubMed Web of Science ®Google Scholar
• Ben-Shahar O, Keeley P, Cook M, Brake W, Joyce M, Nyffeler M, Heston R, Ettenberg A. 2007. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res. 1131(1):220–228.
   PubMed Web of Science ®Google Scholar
• Biondo A-M, Clements RL, Hayes DJ, Eshpeter B, Greenshaw AJ. 2005. NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats. Psychopharmacology. 179(1):189–197.
   PubMed Web of Science ®Google Scholar
• Bokor G, Anderson PD. 2014. Ketamine: an update on its abuse. J Pharm Pract. 27(6):582–586.
   PubMedGoogle Scholar
• Boutros N, Semenova S, Markou A. 2016. Adolescent alcohol exposure decreased sensitivity to nicotine in adult Wistar rats. Addict Biol. 21(4):826–834.
   PubMed Web of Science ®Google Scholar
• Caffino L, Piva A, Giannotti G, Di Chio M, Mottarlini F, Venniro M, Yew DT, Chiamulera C, Fumagalli F. 2017. Ketamine self-administration reduces the homeostasis of the glutamate synapse in the rat brain. Mol Neurobiol. 54(9):7186–7193.
   PubMed Web of Science ®Google Scholar
• Caprioli D, Justinova Z, Venniro M, Shaham Y. 2018. Effect of novel allosteric modulators of metabotropic glutamate receptors on drug self-administration and relapse: a review of preclinical studies and their clinical implications. Biol Psychiatry. 84(3):180–192.
   PubMed Web of Science ®Google Scholar
• Charsouei S, Jabalameli MR, Karimi-Moghadam A. 2020. Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology. Acta Neurol Belg. 120(3):531–544.
   PubMed Web of Science ®Google Scholar
• Cohen A, Koob GF, George O. 2012. Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology. 37(9):2153–2160.
   PubMed Web of Science ®Google Scholar
• Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng L-J, Shaham Y, Marinelli M, Wolf ME. 2008. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature. 454(7200):118–121.
   PubMed Web of Science ®Google Scholar
• Cornish JL, Duffy P, Kalivas PW. 1999. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience. 93(4):1359–1367.
   PubMed Web of Science ®Google Scholar
• Cornish JL, Kalivas PW. 2000. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci. 20(15):RC89.
   PubMed Web of Science ®Google Scholar
• Costa G, De Luca MA, Piras G, Marongiu J, Fattore L, Simola N. 2020. Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies. Neural Regen Res. 15(5):802–816.
   PubMed Web of Science ®Google Scholar
• Crupi R, Impellizzeri D, Cuzzocrea S. 2019. Role of metabotropic glutamate receptors in neurological disorders. Front Mol Neurosci. 12:20.
   PubMed Web of Science ®Google Scholar
• Dalgaard L, Hjortkjaer RK, Regnier B, Nordholm L. 1994. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid. Drug Metab Dispos Biol Fate Chem. 22:289–293.
   PubMed Web of Science ®Google Scholar
• Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, et al. 2019. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 18(11):1045–1057.
   PubMed Web of Science ®Google Scholar
• Doyle SE, Ramôa C, Garber G, Newman J, Toor Z, Lynch WJ. 2014. A shift in the role of glutamatergic signaling in the nucleus accumbens core with the development of an addicted phenotype. Biol Psychiatry. 76(10):810–815.
   PubMed Web of Science ®Google Scholar
• D’Souza MS. 2015. Glutamatergic transmission in drug reward: implications for drug addiction. Front Neurosci. 9:404.
   PubMed Web of Science ®Google Scholar
• Dudić A, Reiner A. 2019. Quinoxalinedione deprotonation is important for glutamate receptor binding. Biol Chem. 400(7):927–938.
   PubMed Web of Science ®Google Scholar
• Farokhnia M, Browning BD, Leggio L. 2019. Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies. Curr Opin Psychiatry. 32(4):255–265.
   PubMed Web of Science ®Google Scholar
• Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P. 2009. Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. Eur Neuropsychopharmacol. 19(7):487–498.
   PubMed Web of Science ®Google Scholar
• Gass JT, Olive MF. 2008. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol. 75(1):218–265.
   PubMed Web of Science ®Google Scholar
• Goodwani S, Saternos H, Alasmari F, Sari Y. 2017. Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder. Neurosci Biobehav Rev. 77:14–31.
   PubMed Web of Science ®Google Scholar
• Gordillo-Salas M, Pascual-Antón R, Ren J, Greer J, Adell A. 2020. Antidepressant-Like Effects of CX717, a Positive Allosteric Modulator of AMPA Receptors. Mol Neurobiol. 57(8):3498–3507.
   PubMed Web of Science ®Google Scholar
• Guercio LA, Hofmann ME, Swinford-Jackson SE, Sigman JS, Wimmer ME, Dell’Acqua ML, Schmidt HD, Pierce RC. 2018. A-kinase anchoring protein 150 (AKAP150) promotes cocaine reinstatement by increasing AMPA receptor transmission in the accumbens shell. Neuropsychopharmacol. 43(6):1395–1404.
   PubMed Web of Science ®Google Scholar
• Hao Y, Martin-Fardon R, Weiss F. 2010. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence. Biol Psychiatry. 68(3):240–248.
   PubMed Web of Science ®Google Scholar
• Harris GC, Aston-Jones G. 2003. Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology. 28(1):73–76.
   PubMed Web of Science ®Google Scholar
• Harris GC, Wimmer M, Byrne R, Aston-Jones G. 2004. Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine. Neuroscience. 129(3):841–847.
   PubMed Web of Science ®Google Scholar
• Huang M-C, Lin S-K. 2020. Ketamine abuse: past and present. In: Hashimoto K, Ide S, Ikeda K, editors. Ketamine: from abused drug to rapid-acting antidepressant. Singapore (Singapore): Springer; p. 1–14.
   Google Scholar
• James MH, Mahler SV, Moorman DE, Aston-Jones G. 2017. A decade of orexin/hypocretin and addiction: where are we now? In: Lawrence AJ, de Lecea L, editors. Behavioral neuroscience of orexin/hypocretin. Current topics in behavioral neurosciences. Cham (Switzerland): Springer International Publishing; p. 247–281.
   Google Scholar
• Jones JL, Mateus CF, Malcolm RJ, Brady KT, Back SE. 2018. Efficacy of ketamine in the treatment of substance use disorders: a systematic review. Front Psychiatry. 9:277. https://doi.org/https://doi.org/10.3389/fpsyt.2018.00277.
   PubMed Web of Science ®Google Scholar
• Karakas E, Regan MC, Furukawa H. 2015. Emerging structural insights into the function of ionotropic glutamate receptors. Trends Biochem Sci. 40(6):328–337.
   PubMed Web of Science ®Google Scholar
• Karila L, Weinstein A, Aubin H-J, Benyamina A, Reynaud M, Batki SL. 2010. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol. 69(6):578–592.
   PubMed Web of Science ®Google Scholar
• Kessler M, Baudry M, Lynch G. 1989. Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites. Brain Res. 489(2):377–382.
   PubMed Web of Science ®Google Scholar
• Knackstedt LA, Kalivas PW. 2009. Glutamate and reinstatement. Curr Opin Pharmacol. 9(1):59–64.
   PubMed Web of Science ®Google Scholar
• Koob G, Kreek MJ. 2007. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 164(8):1149–1159.
   PubMed Web of Science ®Google Scholar
• Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O’Dell LE, Parsons LH, Sanna PP. 2004. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev. 27(8):739–749.
   PubMed Web of Science ®Google Scholar
• Koob GF, Volkow ND. 2016. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 3(8):760–773.
   PubMed Web of Science ®Google Scholar
• Kraus C, Wasserman D, Henter ID, Acevedo-Diaz E, Kadriu B, Zarate Jr CA. 2019. The influence of ketamine on drug discovery in depression. Drug Discov. Today 24:2033–2043.
   Google Scholar
• Larson SA, Desai R, Kates FR. 2019. Concerns about heroin, cocaine and methamphetamine: prevalence and correlates of at-risk users from 2015 National Survey on Drug Use and Health. J Subst Use. 24(2):206–211.
   Web of Science ®Google Scholar
• Lees GJ. 2000. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs. 59(1):33–78.
   PubMed Web of Science ®Google Scholar
• Levin ED, Wells C, Yao L, Guo W, Nangia A, Howard S, Pippen E, Hawkey AB, Rose JE, Rezvani AH, et al. 2019. Chronic memantine decreases nicotine self-administration in rats. Eur J Pharmacol. 861:172592.
   PubMed Web of Science ®Google Scholar
• Lynch WJ, Bakhti-Suroosh A, Abel JM, Davis C. 2021. Shifts in the neurobiological mechanisms motivating cocaine use with the development of an addiction-like phenotype in male rats. Psychopharmacology. 238(3):811–823.
   PubMed Web of Science ®Google Scholar
• Mahler SV, Smith RJ, Aston-Jones G. 2013. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology. 226(4):687–698.
   PubMed Web of Science ®Google Scholar
• McGlinchey EM, James MH, Mahler SV, Pantazis C, Aston-Jones G. 2016. Prelimbic to accumbens core pathway is recruited in a dopamine-dependent manner to drive cued reinstatement of cocaine seeking. J Neurosci. 36(33):8700–8711.
   PubMed Web of Science ®Google Scholar
• Mead AN, Stephens DN. 1999. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. J Pharmacol Exp Ther. 290:9–15.
   PubMed Web of Science ®Google Scholar
• O’Connor SL, Fragale JE, James MH, Aston-Jones G. 2020. The dual orexin/hypocretin receptor antagonist suvorexant reduces addiction-like behaviors for the opioid fentanyl. bioRxiv. https://doi.org/https://doi.org/10.1101/2020.04.25.061887.
   Google Scholar
• Panlilio LV, Goldberg SR. 2007. Self-administration of drugs in animals and humans as a model and an investigative tool. Addiction. 102(12):1863–1870.
   PubMed Web of Science ®Google Scholar
• Park W-K, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC. 2002. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci. 22(7):2916–2925.
   PubMed Web of Science ®Google Scholar
• Pierce RC, Meil WM, Kalivas PW. 1997. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology. 133(2):188–195.
   PubMed Web of Science ®Google Scholar
• Polosa R, Benowitz NL. 2011. Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci. 32(5):281–289.
   PubMed Web of Science ®Google Scholar
• Pushparaj A, Kim AS, Musiol M, Trigo JM, Le Foll B. 2015. Involvement of the rostral agranular insular cortex in nicotine self-administration in rats. Behav Brain Res. 290:77–83.
   PubMed Web of Science ®Google Scholar
• Ramôa CP, Doyle SE, Lycas MD, Chernau AK, Lynch WJ. 2014. Diminished role of dopamine D1-receptor signaling with the development of an addicted phenotype in rats. Biol Psychiatry. 76(1):8–14.
   PubMed Web of Science ®Google Scholar
• Reichel CM, Bevins RA. 2009. Forced abstinence model of relapse to study pharmacological treatments of substance use disorder. Curr Drug Abuse Rev. 2(2):184–194.
   PubMedGoogle Scholar
• Rezvani AH, Levin ED, Cauley M, Getachew B, Tizabi Y. 2017. Ketamine differentially attenuates alcohol intake in male versus female alcohol preferring (P) rats. J Drug Alcohol Res. 6:1–6.
   Google Scholar
• Rezvani AH, Tizabi Y, Slade S, Getachew B, Levin ED. ED. 2018. Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats. Neurosci Lett. 668:98–102.
   PubMed Web of Science ®Google Scholar
• Rosen LJ, Galili T, Kott J, Goodman M, Freedman LS. 2018. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Addiction. 113(5):805–816.
   PubMed Web of Science ®Google Scholar
• Ruda-Kucerova J, Amchova P, Babinska Z, Dusek L, Micale V, Sulcova A. 2015. Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats. Front Psychiatry. 6:91.
   PubMed Web of Science ®Google Scholar
• Ruda-Kucerova J, Babinska Z, Amchova P, Stark T, Drago F, Sulcova A, Micale V. 2017. Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats. World J Biol Psychiatry. 18(2):129–142.
   PubMed Web of Science ®Google Scholar
• Ruda-Kucerova J, Babinska Z, Luptak M, Getachew B, Tizabi Y. 2018. Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats. Neurosci Lett. 666:175–180.
   PubMed Web of Science ®Google Scholar
• Ruda-Kucerova J, Babinska Z, Stark T, Micale V. 2017. Suppression of methamphetamine self-administration by ketamine pre-treatment is absent in the methylazoxymethanol (MAM) rat model of schizophrenia. Neurotox Res. 32(1):121–133.
   PubMed Web of Science ®Google Scholar
• Schmidt HD, Pierce RC. 2010. Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci. 1187:35–75.
   PubMed Web of Science ®Google Scholar
• Schmitz JM, Wardle MC, Weaver MF, Heads AM, Yoon JH, Lane SD. 2019. Pharmacological treatment of psychostimulant use disorders. In: APA handbook of psychopharmacology. APA handbooks in psychology® series. Washington (DC): American Psychological Association. p. 533–560.
   Google Scholar
• Shalev U, Grimm JW, Shaham Y. 2002. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev. 54(1):1–42.
   PubMed Web of Science ®Google Scholar
• Siahposht-Khachaki A, Fatahi Z, Yans A, Khodagholi F, Haghparast A. 2017. Involvement of AMPA/kainate glutamate receptor in the extinction and reinstatement of morphine-induced conditioned place preference: a behavioral and molecular study. Cell Mol Neurobiol. 37(2):315–328.
   PubMed Web of Science ®Google Scholar
• Sial OK, Parise EM, Parise LF, Gnecco T, Bolaños-Guzmán CA. 2020. Ketamine: The final frontier or another depressing end? Behav. Brain Res. 383:112508.
   Google Scholar
• Sibanda NC, Kornhaber R, Hunt GE, Morley K, Cleary M. 2019. Prevalence and risk factors of emergency department presentations with methamphetamine intoxication or dependence: a systematic review and meta-analysis. Issues Ment Health Nurs. 40(7):567–578.
   PubMed Web of Science ®Google Scholar
• Siska F, Amchova P, Kuruczova D, Tizabi Y, Ruda-Kucerova J. Effects of low-dose alcohol exposure in adolescence on subsequent alcohol drinking in adulthood in a rat model of depression. World J. Biol. Psychiatry. 2021. doi:https://doi.org/10.1080/15622975.2021.1907717.
   Google Scholar
• Spanagel R. 2017. Animal models of addiction. Dialogues Clin Neurosci. 19:247–258.
   PubMed Web of Science ®Google Scholar
• Spencer S, Kalivas PW. 2017. Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol. 20(10):797–812.
   PubMed Web of Science ®Google Scholar
• Uhl GR, Koob GF, Cable J. 2019. The neurobiology of addiction. Ann N Y Acad Sci. 1451(1):5–28.
   PubMed Web of Science ®Google Scholar
• Van Nest D, Hernandez NS, Kranzler HR, Pierce RC, Schmidt HD. 2017. Effects of LY466195, a selective kainate receptor antagonist, on ethanol preference and drinking in rats. Neurosci Lett. 639:8–12.
   PubMed Web of Science ®Google Scholar
• Vanderschuren LJMJ, Kalivas PW. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 151(2–3):99–120.
   PubMed Web of Science ®Google Scholar
• Venniro M, Caprioli D, Shaham Y. 2016. Animal models of drug relapse and craving: from drug priming-induced reinstatement to incubation of craving after voluntary abstinence. Prog Brain Res. 224:25–52.
   PubMed Web of Science ®Google Scholar
• WHO. 2019. WHO report on the global tobacco epidemic 2019. Geneva (Switzerland): WHO; [accessed 2020 March 22]. http://www.who.int/tobacco/global_report/en/
   Google Scholar